1. Coffee consumption and cardiovascular health in the general population. (3rd October 2022) Authors: Wenzel, J; Senftinger, J; Borof, K; Ojeda, F; Aarabi, G; Beikler, T; Mayer, C; Behrendt, C; Walther, C; Zyriax, B C; Twerenbold, R; Blankenberg, S; Nikorowitsch, J Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LHC forward physics. (17th October 2016) Authors: Akiba, K; Akbiyik, M; Albrow, M; Arneodo, M; Avati, V; Baechler, J; Baillie, O Villalobos; Bartalini, P; Bartels, J; Baur, S; Baus, C; Beaumont, W; Behrens, U; Berge, D; Berretti, M; Bossini, E; Boussarie, R; Brodsky, S; Broz, M; Bruschi, M Journal: Journal of physics Issue: Volume 43:Number 11(2016:Nov.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Maternal risk factors and adverse birth outcomes associated with HELLP syndrome: a population‐based study. (13th April 2020) Authors: Lisonkova, S; Razaz, N; Sabr, Y; Muraca, GM; Boutin, A; Mayer, C; Joseph, KS; Kramer, MS Journal: BJOG Issue: Volume 127:Number 10(2020) Page Start: 1189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P032 Host transcriptome signatures in human fecal-washes predict histological remission in IBD patients. (21st January 2022) Authors: Ungar, B; Yavzori, M; Fudim, E; Picard, O; Kopylov, U; Eliakim, R; Shouval, D; Levin, Y; Savidor, A; Ben-Moshe, S; Manco, R; Dan, S; Egozi, A; Bahar Halpern, K; Mayer, C; Barshak, I; Ben-Horin, S; Itzkovitz, S Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P777 Deployment of an artificial intelligence tool for precision medicine in ulcerative colitis: Preliminary data from 8 globally distributed clinical sites. (30th January 2023) Authors: Peyrin-Biroulet, L; Rubin, D; Weber, C; Adsul, S; Freire, M; Biedermann, L; Koelzer, V; Bressler, B; Xiong, W; Niess, J; Matthias Matter, M M; Kopylov, U; Barshack, I; Mayer, C; Magro, F; Carneiro, F; Maharshak, N; Greenberg, A; Hart, S; Dehmeshki, J Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i910 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. S119: PRELIMINARY RESULTS OF A PHASE 1 STUDY IN HEALTHY SUBJECTS ADMINISTERED INCLACUMAB, A FULLY HUMAN IGG4 ANTI-P-SELECTIN MONOCLONAL ANTIBODY IN DEVELOPMENT FOR TREATMENT OF SICKLE CELL DISEASE. (31st January 2022) Authors: Mayer, C; Cooper, D; Redfern, A; Geng, X; Shi, J; Zutphen-van Geffen, M; Kuan, I; Koek, K; Kastrissios, H; Patel, K; Davis, M; Yue, P Journal: HemaSphere Issue: Volume 6(2022)Supplement 1 Page Start: 10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗